avrg: GSE58827: Dynamics of the Mouse Liver
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Cux1
|
ENSMUSG00000029705.11 | cut-like homeobox 1 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Cux1 | mm10_v2_chr5_-_136567307_136567445 | -0.64 | 2.8e-05 | Click! |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.5 | 22.1 | GO:0071718 | sodium-independent icosanoid transport(GO:0071718) |
3.3 | 9.9 | GO:1903002 | regulation of lipid transport across blood brain barrier(GO:1903000) positive regulation of lipid transport across blood brain barrier(GO:1903002) |
2.8 | 8.5 | GO:0019442 | tryptophan catabolic process to acetyl-CoA(GO:0019442) |
1.9 | 62.7 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
1.8 | 5.5 | GO:0071395 | response to jasmonic acid(GO:0009753) cellular response to jasmonic acid stimulus(GO:0071395) |
1.7 | 6.8 | GO:0030091 | protein repair(GO:0030091) |
1.6 | 6.6 | GO:1903964 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
1.4 | 4.2 | GO:0001868 | regulation of complement activation, lectin pathway(GO:0001868) negative regulation of complement activation, lectin pathway(GO:0001869) |
1.4 | 5.5 | GO:0010901 | regulation of very-low-density lipoprotein particle remodeling(GO:0010901) |
1.2 | 4.9 | GO:0015744 | succinate transport(GO:0015744) |
1.2 | 4.8 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
1.2 | 3.5 | GO:0006533 | fumarate metabolic process(GO:0006106) aspartate biosynthetic process(GO:0006532) aspartate catabolic process(GO:0006533) |
1.1 | 4.3 | GO:0009992 | cellular water homeostasis(GO:0009992) |
1.1 | 6.4 | GO:0072592 | oxygen metabolic process(GO:0072592) |
1.0 | 5.2 | GO:0001692 | histamine metabolic process(GO:0001692) |
1.0 | 9.0 | GO:0071569 | protein ufmylation(GO:0071569) |
1.0 | 4.9 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
0.9 | 2.8 | GO:0046900 | tetrahydrofolylpolyglutamate metabolic process(GO:0046900) |
0.9 | 9.5 | GO:0097421 | liver regeneration(GO:0097421) |
0.8 | 13.4 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.8 | 5.8 | GO:0070777 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
0.7 | 5.2 | GO:0030969 | mRNA splicing via endonucleolytic cleavage and ligation involved in unfolded protein response(GO:0030969) mRNA splicing, via endonucleolytic cleavage and ligation(GO:0070054) mRNA endonucleolytic cleavage involved in unfolded protein response(GO:0070055) |
0.7 | 2.9 | GO:0014916 | regulation of lung blood pressure(GO:0014916) |
0.7 | 15.0 | GO:0031340 | positive regulation of vesicle fusion(GO:0031340) |
0.7 | 3.5 | GO:0009115 | xanthine catabolic process(GO:0009115) |
0.6 | 2.5 | GO:0072719 | cellular response to cisplatin(GO:0072719) |
0.6 | 4.6 | GO:0001766 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
0.6 | 1.7 | GO:0034443 | negative regulation of lipoprotein oxidation(GO:0034443) multicellular organism lipid catabolic process(GO:0044240) |
0.6 | 1.7 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
0.5 | 2.2 | GO:0036343 | psychomotor behavior(GO:0036343) |
0.5 | 2.2 | GO:0032497 | detection of lipopolysaccharide(GO:0032497) |
0.5 | 2.2 | GO:0035963 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
0.5 | 2.7 | GO:0046416 | D-amino acid metabolic process(GO:0046416) D-serine metabolic process(GO:0070178) |
0.5 | 3.5 | GO:0034214 | protein hexamerization(GO:0034214) |
0.5 | 2.9 | GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
0.5 | 5.3 | GO:0015868 | purine ribonucleotide transport(GO:0015868) |
0.5 | 1.4 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.4 | 1.3 | GO:0061181 | regulation of chondrocyte development(GO:0061181) |
0.4 | 2.7 | GO:0010636 | positive regulation of mitochondrial fusion(GO:0010636) |
0.4 | 1.7 | GO:0014028 | notochord formation(GO:0014028) |
0.4 | 1.3 | GO:0035602 | fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow(GO:0035602) fibroblast growth factor receptor signaling pathway involved in hemopoiesis(GO:0035603) fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow(GO:0035604) coronal suture morphogenesis(GO:0060365) |
0.4 | 1.3 | GO:1902871 | cerebral cortex GABAergic interneuron fate commitment(GO:0021893) positive regulation of neural retina development(GO:0061075) positive regulation of retina development in camera-type eye(GO:1902868) positive regulation of amacrine cell differentiation(GO:1902871) |
0.4 | 4.8 | GO:0052697 | flavonoid glucuronidation(GO:0052696) xenobiotic glucuronidation(GO:0052697) |
0.4 | 3.7 | GO:0016127 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.4 | 1.5 | GO:0045329 | carnitine biosynthetic process(GO:0045329) |
0.4 | 1.4 | GO:0050787 | detoxification of mercury ion(GO:0050787) |
0.3 | 1.7 | GO:2001274 | negative regulation of glucose import in response to insulin stimulus(GO:2001274) |
0.3 | 2.7 | GO:0019695 | choline metabolic process(GO:0019695) |
0.3 | 1.6 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
0.3 | 0.9 | GO:0035622 | intrahepatic bile duct development(GO:0035622) |
0.3 | 2.2 | GO:2000124 | regulation of endocannabinoid signaling pathway(GO:2000124) |
0.3 | 1.2 | GO:0048294 | negative regulation of isotype switching to IgE isotypes(GO:0048294) |
0.3 | 3.4 | GO:0072615 | interleukin-17 secretion(GO:0072615) |
0.3 | 1.2 | GO:0006032 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
0.3 | 2.1 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
0.3 | 0.9 | GO:1990927 | calcium ion regulated lysosome exocytosis(GO:1990927) |
0.3 | 16.6 | GO:0006953 | acute-phase response(GO:0006953) |
0.3 | 0.9 | GO:0046710 | GDP metabolic process(GO:0046710) |
0.3 | 0.9 | GO:0006538 | glutamate catabolic process(GO:0006538) |
0.3 | 4.2 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
0.3 | 4.4 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
0.3 | 0.8 | GO:0035880 | embryonic nail plate morphogenesis(GO:0035880) |
0.3 | 1.3 | GO:0090403 | oxidative stress-induced premature senescence(GO:0090403) |
0.3 | 1.3 | GO:0032237 | activation of store-operated calcium channel activity(GO:0032237) |
0.3 | 1.0 | GO:0048807 | female genitalia morphogenesis(GO:0048807) |
0.3 | 2.6 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
0.3 | 0.8 | GO:0060399 | positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
0.2 | 2.2 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
0.2 | 2.0 | GO:0045345 | MHC class I biosynthetic process(GO:0045341) regulation of MHC class I biosynthetic process(GO:0045343) positive regulation of MHC class I biosynthetic process(GO:0045345) |
0.2 | 2.0 | GO:0070813 | hydrogen sulfide metabolic process(GO:0070813) |
0.2 | 2.2 | GO:1902669 | positive regulation of axon guidance(GO:1902669) |
0.2 | 1.7 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
0.2 | 0.7 | GO:0090650 | response to oxygen-glucose deprivation(GO:0090649) cellular response to oxygen-glucose deprivation(GO:0090650) |
0.2 | 0.9 | GO:0045054 | constitutive secretory pathway(GO:0045054) |
0.2 | 2.3 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.2 | 0.9 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
0.2 | 2.5 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.2 | 2.2 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
0.2 | 0.9 | GO:1903347 | negative regulation of bicellular tight junction assembly(GO:1903347) |
0.2 | 0.6 | GO:0016131 | brassinosteroid metabolic process(GO:0016131) brassinosteroid biosynthetic process(GO:0016132) |
0.2 | 0.6 | GO:1905035 | regulation of antifungal innate immune response(GO:1905034) negative regulation of antifungal innate immune response(GO:1905035) |
0.2 | 1.0 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
0.2 | 1.0 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
0.2 | 0.6 | GO:2000729 | positive regulation of mesenchymal cell proliferation involved in ureter development(GO:2000729) |
0.2 | 3.8 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.2 | 0.8 | GO:0070295 | renal water absorption(GO:0070295) |
0.2 | 5.1 | GO:0046688 | response to copper ion(GO:0046688) |
0.2 | 1.1 | GO:0039530 | MDA-5 signaling pathway(GO:0039530) |
0.2 | 0.9 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
0.2 | 0.7 | GO:0046909 | intermembrane transport(GO:0046909) protein transport from ciliary membrane to plasma membrane(GO:1903445) |
0.2 | 0.7 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
0.2 | 1.5 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.2 | 2.5 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
0.2 | 5.1 | GO:0015985 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
0.2 | 1.1 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.2 | 2.3 | GO:0002934 | desmosome organization(GO:0002934) |
0.2 | 0.9 | GO:0072092 | ureteric bud invasion(GO:0072092) |
0.2 | 2.1 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
0.1 | 1.0 | GO:0035590 | purinergic nucleotide receptor signaling pathway(GO:0035590) |
0.1 | 0.7 | GO:0021650 | vestibulocochlear nerve formation(GO:0021650) |
0.1 | 0.7 | GO:0051541 | elastin metabolic process(GO:0051541) |
0.1 | 0.3 | GO:0060460 | left lung development(GO:0060459) left lung morphogenesis(GO:0060460) |
0.1 | 2.3 | GO:0016558 | protein import into peroxisome matrix(GO:0016558) |
0.1 | 0.8 | GO:0015889 | cobalamin transport(GO:0015889) |
0.1 | 0.4 | GO:0046049 | UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
0.1 | 2.2 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.1 | 9.3 | GO:0022900 | electron transport chain(GO:0022900) |
0.1 | 0.5 | GO:1903542 | protein to membrane docking(GO:0022615) negative regulation of exosomal secretion(GO:1903542) |
0.1 | 0.4 | GO:1900620 | acetylcholine biosynthetic process(GO:0008292) acetate ester biosynthetic process(GO:1900620) |
0.1 | 1.0 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.1 | 0.4 | GO:0099548 | retrograde trans-synaptic signaling by soluble gas(GO:0098923) trans-synaptic signaling by nitric oxide(GO:0099548) |
0.1 | 1.0 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.1 | 3.7 | GO:0019236 | response to pheromone(GO:0019236) |
0.1 | 0.6 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) |
0.1 | 4.4 | GO:0051180 | vitamin transport(GO:0051180) |
0.1 | 1.4 | GO:0042407 | cristae formation(GO:0042407) |
0.1 | 0.7 | GO:0042420 | dopamine catabolic process(GO:0042420) |
0.1 | 0.3 | GO:1902527 | positive regulation of protein monoubiquitination(GO:1902527) |
0.1 | 1.0 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
0.1 | 0.3 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.1 | 0.4 | GO:0061734 | parkin-mediated mitophagy in response to mitochondrial depolarization(GO:0061734) |
0.1 | 0.9 | GO:0016114 | terpenoid biosynthetic process(GO:0016114) |
0.1 | 0.6 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
0.1 | 0.5 | GO:0021886 | hypothalamus gonadotrophin-releasing hormone neuron differentiation(GO:0021886) hypothalamus gonadotrophin-releasing hormone neuron development(GO:0021888) |
0.1 | 0.3 | GO:0007262 | STAT protein import into nucleus(GO:0007262) |
0.1 | 2.4 | GO:0014002 | astrocyte development(GO:0014002) |
0.1 | 1.5 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.1 | 0.3 | GO:1902303 | negative regulation of potassium ion export(GO:1902303) |
0.1 | 0.9 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
0.1 | 3.4 | GO:0051353 | positive regulation of oxidoreductase activity(GO:0051353) |
0.1 | 0.2 | GO:0042697 | menopause(GO:0042697) |
0.1 | 1.5 | GO:0021854 | hypothalamus development(GO:0021854) |
0.1 | 0.2 | GO:0098970 | receptor diffusion trapping(GO:0098953) postsynaptic neurotransmitter receptor diffusion trapping(GO:0098970) neurotransmitter receptor diffusion trapping(GO:0099628) |
0.1 | 0.6 | GO:0017062 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
0.1 | 0.6 | GO:0009240 | isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate metabolic process(GO:0046490) |
0.1 | 7.0 | GO:0009062 | fatty acid catabolic process(GO:0009062) |
0.1 | 0.6 | GO:0048207 | vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) |
0.1 | 0.2 | GO:0006436 | tryptophanyl-tRNA aminoacylation(GO:0006436) |
0.1 | 0.4 | GO:0014886 | transition between slow and fast fiber(GO:0014886) |
0.1 | 5.7 | GO:0046928 | regulation of neurotransmitter secretion(GO:0046928) |
0.1 | 0.3 | GO:0014732 | skeletal muscle atrophy(GO:0014732) |
0.1 | 0.2 | GO:0001806 | type IV hypersensitivity(GO:0001806) |
0.1 | 0.8 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.1 | 0.3 | GO:0002278 | eosinophil activation involved in immune response(GO:0002278) eosinophil mediated immunity(GO:0002447) eosinophil degranulation(GO:0043308) |
0.1 | 1.0 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.1 | 0.7 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.1 | 0.7 | GO:0060576 | intestinal epithelial cell development(GO:0060576) |
0.1 | 3.2 | GO:0048873 | homeostasis of number of cells within a tissue(GO:0048873) |
0.1 | 1.2 | GO:0048490 | anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
0.1 | 0.4 | GO:0034375 | high-density lipoprotein particle remodeling(GO:0034375) |
0.1 | 0.9 | GO:1903861 | positive regulation of dendrite extension(GO:1903861) |
0.1 | 1.0 | GO:0010566 | regulation of ketone biosynthetic process(GO:0010566) |
0.1 | 0.5 | GO:1904321 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
0.1 | 0.6 | GO:0002155 | regulation of thyroid hormone mediated signaling pathway(GO:0002155) |
0.1 | 0.3 | GO:0040032 | post-embryonic body morphogenesis(GO:0040032) |
0.1 | 0.3 | GO:1990000 | amyloid fibril formation(GO:1990000) |
0.1 | 2.6 | GO:0006695 | cholesterol biosynthetic process(GO:0006695) secondary alcohol biosynthetic process(GO:1902653) |
0.1 | 0.3 | GO:0033505 | ventral midline development(GO:0007418) floor plate formation(GO:0021508) floor plate morphogenesis(GO:0033505) |
0.1 | 0.2 | GO:0032430 | reduction of food intake in response to dietary excess(GO:0002023) positive regulation of phospholipase A2 activity(GO:0032430) |
0.1 | 2.9 | GO:0036465 | synaptic vesicle recycling(GO:0036465) |
0.1 | 3.4 | GO:0007566 | embryo implantation(GO:0007566) |
0.0 | 0.6 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
0.0 | 0.3 | GO:0007198 | adenylate cyclase-inhibiting serotonin receptor signaling pathway(GO:0007198) |
0.0 | 0.2 | GO:0045950 | negative regulation of mitotic recombination(GO:0045950) |
0.0 | 0.5 | GO:0046037 | GMP metabolic process(GO:0046037) |
0.0 | 0.6 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
0.0 | 0.3 | GO:0051715 | cytolysis in other organism(GO:0051715) |
0.0 | 4.3 | GO:0006487 | protein N-linked glycosylation(GO:0006487) |
0.0 | 0.6 | GO:0060253 | negative regulation of glial cell proliferation(GO:0060253) |
0.0 | 4.7 | GO:0006694 | steroid biosynthetic process(GO:0006694) |
0.0 | 0.9 | GO:0035634 | response to stilbenoid(GO:0035634) |
0.0 | 3.3 | GO:0060395 | SMAD protein signal transduction(GO:0060395) |
0.0 | 1.0 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.0 | 1.2 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
0.0 | 0.3 | GO:0019388 | galactose catabolic process(GO:0019388) |
0.0 | 2.4 | GO:0006749 | glutathione metabolic process(GO:0006749) |
0.0 | 1.0 | GO:0048240 | sperm capacitation(GO:0048240) |
0.0 | 0.7 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
0.0 | 0.7 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
0.0 | 0.7 | GO:0006767 | water-soluble vitamin metabolic process(GO:0006767) |
0.0 | 0.6 | GO:2000310 | regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
0.0 | 0.5 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.0 | 7.2 | GO:0010466 | negative regulation of peptidase activity(GO:0010466) |
0.0 | 0.4 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.0 | 0.3 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.0 | 1.4 | GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
0.0 | 0.3 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
0.0 | 0.5 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
0.0 | 2.0 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.0 | 0.8 | GO:0090662 | energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
0.0 | 0.3 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.0 | 0.3 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
0.0 | 0.3 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
0.0 | 0.4 | GO:0043248 | proteasome assembly(GO:0043248) |
0.0 | 0.6 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
0.0 | 0.4 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
0.0 | 0.6 | GO:0035024 | negative regulation of Rho protein signal transduction(GO:0035024) |
0.0 | 0.4 | GO:1902260 | negative regulation of delayed rectifier potassium channel activity(GO:1902260) |
0.0 | 0.5 | GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
0.0 | 0.2 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
0.0 | 0.6 | GO:0061157 | mRNA destabilization(GO:0061157) |
0.0 | 0.0 | GO:0050968 | detection of chemical stimulus involved in sensory perception of pain(GO:0050968) |
0.0 | 0.8 | GO:0071425 | hematopoietic stem cell proliferation(GO:0071425) |
0.0 | 0.3 | GO:0045899 | positive regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045899) |
0.0 | 0.5 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
0.0 | 0.9 | GO:0007257 | activation of JUN kinase activity(GO:0007257) |
0.0 | 0.4 | GO:0031440 | regulation of mRNA 3'-end processing(GO:0031440) |
0.0 | 0.7 | GO:0010107 | potassium ion import(GO:0010107) |
0.0 | 0.4 | GO:0045026 | plasma membrane fusion(GO:0045026) |
0.0 | 0.3 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
0.0 | 1.2 | GO:0000187 | activation of MAPK activity(GO:0000187) |
0.0 | 0.2 | GO:0051026 | chiasma assembly(GO:0051026) |
0.0 | 0.2 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.0 | 0.5 | GO:0006383 | transcription from RNA polymerase III promoter(GO:0006383) |
0.0 | 0.2 | GO:0090141 | positive regulation of mitochondrial fission(GO:0090141) |
0.0 | 0.5 | GO:0006182 | cGMP biosynthetic process(GO:0006182) |
0.0 | 0.2 | GO:0042104 | positive regulation of activated T cell proliferation(GO:0042104) |
0.0 | 0.2 | GO:0060539 | diaphragm development(GO:0060539) |
0.0 | 0.5 | GO:0021680 | cerebellar Purkinje cell layer development(GO:0021680) |
0.0 | 0.4 | GO:0051443 | positive regulation of ubiquitin-protein transferase activity(GO:0051443) |
0.0 | 0.3 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
0.0 | 0.2 | GO:0000338 | protein deneddylation(GO:0000338) |
0.0 | 0.4 | GO:0030968 | endoplasmic reticulum unfolded protein response(GO:0030968) |
0.0 | 1.0 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.4 | 9.4 | GO:0044279 | other organism cell membrane(GO:0044218) other organism membrane(GO:0044279) |
2.0 | 9.9 | GO:0034365 | discoidal high-density lipoprotein particle(GO:0034365) |
0.9 | 6.2 | GO:0005796 | Golgi lumen(GO:0005796) |
0.5 | 2.1 | GO:0000818 | nuclear MIS12/MIND complex(GO:0000818) |
0.4 | 2.7 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
0.4 | 3.1 | GO:1990604 | AIP1-IRE1 complex(GO:1990597) IRE1-TRAF2-ASK1 complex(GO:1990604) |
0.4 | 1.3 | GO:0042272 | nuclear RNA export factor complex(GO:0042272) |
0.4 | 1.6 | GO:0070552 | BRISC complex(GO:0070552) |
0.4 | 4.0 | GO:0005579 | membrane attack complex(GO:0005579) |
0.4 | 4.8 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.4 | 6.6 | GO:0042627 | chylomicron(GO:0042627) |
0.4 | 5.1 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
0.3 | 1.7 | GO:0030891 | VCB complex(GO:0030891) |
0.3 | 3.2 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
0.3 | 1.7 | GO:0071817 | MMXD complex(GO:0071817) |
0.3 | 2.1 | GO:0000836 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
0.3 | 23.3 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.3 | 1.8 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.3 | 10.1 | GO:0030673 | axolemma(GO:0030673) |
0.2 | 5.1 | GO:0005922 | connexon complex(GO:0005922) |
0.2 | 1.0 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.2 | 1.5 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.2 | 2.6 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.2 | 4.6 | GO:0043218 | compact myelin(GO:0043218) |
0.1 | 6.8 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.1 | 2.4 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.1 | 0.3 | GO:0016939 | kinesin II complex(GO:0016939) |
0.1 | 10.6 | GO:0070469 | respiratory chain(GO:0070469) |
0.1 | 1.0 | GO:0036128 | CatSper complex(GO:0036128) |
0.1 | 1.4 | GO:0097470 | ribbon synapse(GO:0097470) |
0.1 | 1.4 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.1 | 2.9 | GO:0005614 | interstitial matrix(GO:0005614) |
0.1 | 0.7 | GO:0002081 | outer acrosomal membrane(GO:0002081) |
0.1 | 2.2 | GO:0043196 | varicosity(GO:0043196) |
0.1 | 0.5 | GO:1990393 | 3M complex(GO:1990393) |
0.1 | 6.9 | GO:0031903 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
0.1 | 0.6 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.1 | 1.4 | GO:0005639 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) |
0.1 | 7.4 | GO:0042579 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.1 | 0.9 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
0.1 | 0.4 | GO:1990635 | proximal dendrite(GO:1990635) |
0.1 | 0.8 | GO:0016272 | prefoldin complex(GO:0016272) |
0.1 | 3.7 | GO:0042645 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.1 | 1.2 | GO:0031083 | BLOC-1 complex(GO:0031083) |
0.1 | 1.3 | GO:0033391 | chromatoid body(GO:0033391) |
0.1 | 0.9 | GO:0042588 | zymogen granule(GO:0042588) |
0.1 | 0.6 | GO:0061617 | MICOS complex(GO:0061617) |
0.1 | 0.8 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
0.1 | 1.0 | GO:0005766 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.1 | 0.9 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.1 | 0.3 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.1 | 0.9 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
0.1 | 0.3 | GO:0048500 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.1 | 0.6 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
0.1 | 1.3 | GO:0044439 | microbody part(GO:0044438) peroxisomal part(GO:0044439) |
0.1 | 0.7 | GO:0098799 | outer mitochondrial membrane protein complex(GO:0098799) |
0.1 | 0.7 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
0.1 | 8.1 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.1 | 89.9 | GO:0005783 | endoplasmic reticulum(GO:0005783) |
0.0 | 3.7 | GO:0031526 | brush border membrane(GO:0031526) |
0.0 | 0.3 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
0.0 | 0.8 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.0 | 0.8 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
0.0 | 4.6 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.0 | 0.5 | GO:0036157 | outer dynein arm(GO:0036157) |
0.0 | 5.1 | GO:0005770 | late endosome(GO:0005770) |
0.0 | 0.2 | GO:1990246 | uniplex complex(GO:1990246) |
0.0 | 0.2 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.0 | 3.5 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
0.0 | 0.9 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.0 | 1.6 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.0 | 0.7 | GO:0044295 | axonal growth cone(GO:0044295) |
0.0 | 0.1 | GO:0070847 | core mediator complex(GO:0070847) |
0.0 | 0.3 | GO:0097542 | ciliary tip(GO:0097542) |
0.0 | 0.5 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.0 | 3.4 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.0 | 0.3 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.0 | 0.4 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.0 | 1.2 | GO:0030139 | endocytic vesicle(GO:0030139) |
0.0 | 0.2 | GO:0002177 | manchette(GO:0002177) |
0.0 | 0.2 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.0 | 0.4 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.0 | 0.5 | GO:0001533 | cornified envelope(GO:0001533) |
0.0 | 0.2 | GO:0098839 | postsynaptic density membrane(GO:0098839) |
0.0 | 1.3 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
0.0 | 0.3 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.1 | 20.5 | GO:0071614 | linoleic acid epoxygenase activity(GO:0071614) |
3.3 | 9.9 | GO:0046911 | metal chelating activity(GO:0046911) |
3.1 | 18.6 | GO:0034875 | oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor(GO:0033695) caffeine oxidase activity(GO:0034875) |
2.8 | 8.4 | GO:0080130 | L-phenylalanine aminotransferase activity(GO:0070546) L-phenylalanine:2-oxoglutarate aminotransferase activity(GO:0080130) |
2.1 | 8.5 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
1.8 | 5.5 | GO:0047006 | 17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity(GO:0047006) |
1.6 | 6.6 | GO:0032896 | palmitoyl-CoA 9-desaturase activity(GO:0032896) |
1.6 | 4.9 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
1.5 | 4.4 | GO:1902271 | D3 vitamins binding(GO:1902271) |
1.4 | 7.2 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
1.3 | 3.8 | GO:0004658 | propionyl-CoA carboxylase activity(GO:0004658) |
1.2 | 4.8 | GO:0004144 | diacylglycerol O-acyltransferase activity(GO:0004144) |
1.1 | 6.8 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
1.1 | 23.2 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
1.0 | 3.0 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
1.0 | 5.8 | GO:0015501 | glutamate:sodium symporter activity(GO:0015501) |
0.9 | 2.7 | GO:0036361 | racemase and epimerase activity, acting on amino acids and derivatives(GO:0016855) racemase activity, acting on amino acids and derivatives(GO:0036361) amino-acid racemase activity(GO:0047661) |
0.9 | 23.6 | GO:0008392 | arachidonic acid epoxygenase activity(GO:0008392) |
0.7 | 4.3 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
0.7 | 3.5 | GO:0004854 | aldehyde oxidase activity(GO:0004031) xanthine dehydrogenase activity(GO:0004854) oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor(GO:0016623) oxidoreductase activity, acting on CH or CH2 groups, NAD or NADP as acceptor(GO:0016726) |
0.7 | 6.8 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.7 | 2.7 | GO:0046997 | oxidoreductase activity, acting on the CH-NH group of donors, flavin as acceptor(GO:0046997) |
0.7 | 3.4 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.7 | 3.4 | GO:0008142 | oxysterol binding(GO:0008142) |
0.7 | 3.3 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.6 | 3.2 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
0.6 | 2.3 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.6 | 2.2 | GO:0000179 | rRNA (adenine-N6,N6-)-dimethyltransferase activity(GO:0000179) |
0.5 | 5.1 | GO:0016724 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.5 | 2.0 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.5 | 3.0 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.5 | 2.9 | GO:0016401 | palmitoyl-CoA oxidase activity(GO:0016401) |
0.5 | 1.5 | GO:0022865 | transmembrane electron transfer carrier(GO:0022865) |
0.5 | 2.9 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
0.5 | 1.4 | GO:0019150 | D-ribulokinase activity(GO:0019150) |
0.5 | 5.9 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.4 | 2.2 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
0.4 | 1.7 | GO:0008802 | betaine-aldehyde dehydrogenase activity(GO:0008802) |
0.4 | 9.1 | GO:0004033 | aldo-keto reductase (NADP) activity(GO:0004033) |
0.4 | 3.6 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
0.4 | 3.4 | GO:1901612 | cardiolipin binding(GO:1901612) |
0.4 | 1.4 | GO:0003844 | 1,4-alpha-glucan branching enzyme activity(GO:0003844) |
0.4 | 13.6 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
0.3 | 2.1 | GO:0060698 | endoribonuclease inhibitor activity(GO:0060698) |
0.3 | 1.0 | GO:0016901 | glycerol-3-phosphate dehydrogenase activity(GO:0004368) oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.3 | 5.3 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.3 | 2.6 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
0.3 | 4.2 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.3 | 7.8 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.3 | 2.4 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.3 | 1.2 | GO:0004568 | chitinase activity(GO:0004568) |
0.3 | 0.9 | GO:0044715 | 8-oxo-dGDP phosphatase activity(GO:0044715) |
0.3 | 0.9 | GO:0004793 | threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
0.3 | 8.3 | GO:0008137 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.3 | 15.5 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.3 | 0.8 | GO:0008390 | testosterone 16-alpha-hydroxylase activity(GO:0008390) |
0.3 | 3.6 | GO:0070403 | NAD+ binding(GO:0070403) |
0.2 | 1.5 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.2 | 0.7 | GO:0030350 | iron-responsive element binding(GO:0030350) |
0.2 | 3.7 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.2 | 6.2 | GO:0001871 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.2 | 0.6 | GO:0047598 | sterol delta7 reductase activity(GO:0009918) 7-dehydrocholesterol reductase activity(GO:0047598) |
0.2 | 5.5 | GO:0001848 | complement binding(GO:0001848) |
0.2 | 0.6 | GO:0031531 | thyrotropin-releasing hormone receptor binding(GO:0031531) |
0.2 | 1.7 | GO:0005347 | ATP transmembrane transporter activity(GO:0005347) ADP transmembrane transporter activity(GO:0015217) |
0.2 | 0.7 | GO:0070740 | tubulin-glutamic acid ligase activity(GO:0070740) |
0.2 | 2.5 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.2 | 0.9 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.2 | 2.6 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.2 | 2.6 | GO:0019865 | immunoglobulin binding(GO:0019865) |
0.2 | 0.9 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.2 | 0.9 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.2 | 0.6 | GO:0004452 | isopentenyl-diphosphate delta-isomerase activity(GO:0004452) |
0.2 | 1.2 | GO:0016618 | hydroxypyruvate reductase activity(GO:0016618) glyoxylate reductase (NADP) activity(GO:0030267) |
0.1 | 3.1 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
0.1 | 1.0 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.1 | 3.5 | GO:0008483 | transaminase activity(GO:0008483) |
0.1 | 4.2 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.1 | 1.0 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
0.1 | 3.8 | GO:0015002 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.1 | 3.5 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
0.1 | 1.3 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.1 | 0.9 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
0.1 | 2.2 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
0.1 | 0.9 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.1 | 0.6 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.1 | 15.9 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.1 | 0.8 | GO:0015288 | porin activity(GO:0015288) |
0.1 | 0.8 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.1 | 0.8 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.1 | 0.8 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.1 | 1.3 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.1 | 2.8 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
0.1 | 0.3 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.1 | 0.3 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.1 | 0.7 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.1 | 2.2 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.1 | 0.8 | GO:0031419 | cobalamin binding(GO:0031419) |
0.1 | 1.5 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.1 | 0.3 | GO:0001847 | opsonin receptor activity(GO:0001847) |
0.1 | 2.0 | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen(GO:0016701) oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
0.1 | 2.6 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.1 | 0.3 | GO:0005459 | UDP-galactose transmembrane transporter activity(GO:0005459) |
0.1 | 0.9 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.1 | 1.2 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
0.1 | 0.2 | GO:0004830 | tryptophan-tRNA ligase activity(GO:0004830) |
0.1 | 1.8 | GO:0016503 | pheromone receptor activity(GO:0016503) |
0.1 | 0.3 | GO:0038100 | nodal binding(GO:0038100) |
0.1 | 2.6 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.1 | 0.3 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.1 | 1.3 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.1 | 0.4 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.1 | 0.2 | GO:0001566 | phorbol ester receptor activity(GO:0001565) non-kinase phorbol ester receptor activity(GO:0001566) |
0.1 | 0.7 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.1 | 0.3 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
0.1 | 0.4 | GO:0050694 | galactose 3-O-sulfotransferase activity(GO:0050694) |
0.1 | 0.3 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.1 | 0.4 | GO:0044547 | DNA topoisomerase binding(GO:0044547) |
0.1 | 1.1 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
0.1 | 2.7 | GO:0005549 | odorant binding(GO:0005549) |
0.1 | 2.1 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.1 | 1.1 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.1 | 2.6 | GO:0050699 | WW domain binding(GO:0050699) |
0.1 | 0.4 | GO:0033265 | choline transmembrane transporter activity(GO:0015220) choline binding(GO:0033265) |
0.1 | 1.4 | GO:0031489 | myosin V binding(GO:0031489) |
0.1 | 2.6 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.1 | 0.3 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
0.0 | 0.5 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.0 | 0.8 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.0 | 0.3 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
0.0 | 1.0 | GO:0070410 | co-SMAD binding(GO:0070410) |
0.0 | 1.8 | GO:0001103 | RNA polymerase II repressing transcription factor binding(GO:0001103) |
0.0 | 0.9 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.0 | 0.5 | GO:0015037 | peptide disulfide oxidoreductase activity(GO:0015037) |
0.0 | 0.4 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.0 | 0.6 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.0 | 0.3 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.0 | 0.8 | GO:0005537 | mannose binding(GO:0005537) |
0.0 | 2.2 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
0.0 | 1.4 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.0 | 0.3 | GO:0051430 | corticotropin-releasing hormone receptor 1 binding(GO:0051430) |
0.0 | 0.4 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.0 | 0.6 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.0 | 0.1 | GO:0001032 | RNA polymerase III type 3 promoter DNA binding(GO:0001032) |
0.0 | 3.3 | GO:0005249 | voltage-gated potassium channel activity(GO:0005249) |
0.0 | 0.1 | GO:1903135 | cupric ion binding(GO:1903135) |
0.0 | 0.5 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.0 | 0.9 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.0 | 0.6 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.0 | 0.3 | GO:0051378 | serotonin binding(GO:0051378) |
0.0 | 0.1 | GO:0004531 | deoxyribonuclease II activity(GO:0004531) |
0.0 | 2.3 | GO:0008170 | N-methyltransferase activity(GO:0008170) |
0.0 | 0.6 | GO:0005521 | lamin binding(GO:0005521) |
0.0 | 1.0 | GO:0003785 | actin monomer binding(GO:0003785) |
0.0 | 1.6 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.0 | 0.1 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.0 | 0.3 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.0 | 0.1 | GO:0033691 | sialic acid binding(GO:0033691) |
0.0 | 1.1 | GO:0015078 | hydrogen ion transmembrane transporter activity(GO:0015078) |
0.0 | 0.5 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
0.0 | 1.0 | GO:0051183 | vitamin transporter activity(GO:0051183) |
0.0 | 0.2 | GO:0030983 | mismatched DNA binding(GO:0030983) |
0.0 | 0.3 | GO:0042166 | acetylcholine binding(GO:0042166) |
0.0 | 0.2 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
0.0 | 0.3 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.0 | 0.5 | GO:0030371 | translation repressor activity(GO:0030371) |
0.0 | 0.5 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.0 | 0.3 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.0 | 0.8 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
0.0 | 0.1 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.0 | 0.7 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.0 | 2.9 | GO:0005125 | cytokine activity(GO:0005125) |
0.0 | 1.2 | GO:0042626 | ATPase activity, coupled to transmembrane movement of substances(GO:0042626) |
0.0 | 3.1 | GO:0030246 | carbohydrate binding(GO:0030246) |
0.0 | 0.3 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
0.0 | 0.1 | GO:0016671 | oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor(GO:0016671) |
0.0 | 0.3 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.0 | 2.3 | GO:0003714 | transcription corepressor activity(GO:0003714) |
0.0 | 1.6 | GO:0016810 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds(GO:0016810) |
0.0 | 0.2 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.0 | 0.2 | GO:0035174 | histone serine kinase activity(GO:0035174) |
0.0 | 0.2 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.0 | 0.0 | GO:0005093 | Rab GDP-dissociation inhibitor activity(GO:0005093) |
0.0 | 0.4 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 6.2 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.2 | 3.8 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.1 | 2.6 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.1 | 2.7 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.1 | 4.9 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.1 | 1.7 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.1 | 2.3 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.1 | 3.1 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.1 | 4.9 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.1 | 14.6 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 0.5 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.0 | 1.3 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.0 | 1.2 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.0 | 1.3 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.0 | 1.8 | PID FGF PATHWAY | FGF signaling pathway |
0.0 | 1.3 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.0 | 0.9 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.0 | 0.6 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.0 | 0.7 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.0 | 0.5 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.0 | 2.4 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.0 | 1.7 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.0 | 0.7 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.0 | 0.3 | PID ALK2 PATHWAY | ALK2 signaling events |
0.0 | 0.3 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.0 | 0.9 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.0 | 0.8 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.0 | 0.5 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.0 | 1.6 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.0 | 0.8 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.0 | 0.7 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.0 | 0.1 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.0 | 0.7 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.0 | 0.7 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.0 | 0.6 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.0 | 0.7 | PID BCR 5PATHWAY | BCR signaling pathway |
0.0 | 0.3 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.0 | 22.1 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.7 | 17.6 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.5 | 8.5 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.4 | 14.7 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.3 | 4.9 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.3 | 3.7 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.3 | 3.2 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.3 | 5.1 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.2 | 3.0 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
0.2 | 5.4 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.2 | 3.8 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.2 | 4.3 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.2 | 3.4 | REACTOME SIGNALING BY NOTCH2 | Genes involved in Signaling by NOTCH2 |
0.2 | 3.7 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.2 | 7.6 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.2 | 2.5 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.2 | 4.2 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.2 | 3.7 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.1 | 1.6 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.1 | 4.4 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.1 | 3.6 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.1 | 3.2 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.1 | 2.9 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.1 | 1.2 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.1 | 3.7 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.1 | 1.1 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
0.1 | 3.3 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.1 | 2.3 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.1 | 2.2 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.1 | 1.7 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.1 | 0.7 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.1 | 2.0 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.1 | 0.8 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.1 | 1.3 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
0.1 | 0.8 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.1 | 3.1 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.1 | 2.7 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.1 | 0.9 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.1 | 0.7 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.1 | 0.6 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.1 | 8.2 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.0 | 0.3 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.0 | 1.6 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.0 | 2.9 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.0 | 1.3 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.0 | 1.7 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
0.0 | 0.6 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
0.0 | 0.7 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.0 | 0.7 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.0 | 3.3 | REACTOME UNFOLDED PROTEIN RESPONSE | Genes involved in Unfolded Protein Response |
0.0 | 1.4 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.0 | 2.4 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.0 | 1.1 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.0 | 2.6 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.0 | 0.5 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
0.0 | 0.2 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.0 | 5.6 | REACTOME TRANSMISSION ACROSS CHEMICAL SYNAPSES | Genes involved in Transmission across Chemical Synapses |
0.0 | 0.5 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.0 | 0.7 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.0 | 0.4 | REACTOME PROCESSING OF INTRONLESS PRE MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
0.0 | 2.0 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.0 | 0.3 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.0 | 1.2 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.0 | 0.3 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.0 | 0.3 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.0 | 0.6 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.0 | 0.7 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.0 | 0.3 | REACTOME ELONGATION ARREST AND RECOVERY | Genes involved in Elongation arrest and recovery |
0.0 | 0.5 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.0 | 0.9 | REACTOME PI METABOLISM | Genes involved in PI Metabolism |
0.0 | 0.2 | REACTOME MEIOSIS | Genes involved in Meiosis |
0.0 | 0.3 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |